Jereczek-Fossa Barbara A, Badzio Andrzej, Jassem Jacek
Department of Radiation Oncology, European Institute of Oncology, 435 via Ripamonti, 20141 Milan, Italy.
Radiother Oncol. 2004 Aug;72(2):175-81. doi: 10.1016/j.radonc.2004.04.006.
Postoperative radiotherapy in endometrial cancer reduces the risk of local relapse but is also associated with substantial acute and late reactions. The aim of our study was to evaluate time without tumor symptoms and toxicity (TWIST) in a consecutive series of 317 endometrial cancer patients administered postoperative irradiation.
Both low-dose rate brachytherapy (BRT) and external beam irradiation (EBRT) were applied in 247 patients (78%), only BRT--in 49 (15%) and only EBRT--in 21 patients (7%). Median follow-up was 7.3 years (range, 4-21 years). TWIST analysis based on actuarial freedom from recurrent disease and from late radiotherapy effects was performed with the use of Kaplan-Meier method. The impact of patient- and treatment-related factors on TWIST was assessed with uni- and multivariate tests.
Five-year overall survival was 78%, and five-year disease free survival--75%. Recurrence occurred in 70 patients (22%), of whom in 11 (3.5%)--exclusively in the pelvis. Acute and late reactions of any grade occurred in 268 (85%) and 158 patients (51%), respectively. Late bowel effects of any grade were observed in 41% of patients. Severe late effects occurred in 35 patients (11%). Actuarial probability of two- and five-year survival free of disease and severe (grades 3 or 4) late effects (TWIST) was 84% and 71%, respectively (median TWIST, 16.2 years). When all-grade late effects were considered, two- and five-year TWIST probability was 50 and 30%, respectively, and median TWIST was only 2.0 years. When both acute and late reactions were taken into account, median TWIST was 22 months. In unifactorial test, higher age ( P = 0.013) FIGO stage ( P < 0.001) total radiotherapy dose ( P < 0.001) normalized total dose based on linear-quadratic model ( P = 0.001) EBRT fraction dose ( P < 0.001) and use of cesium BRT ( P = 0.042) were correlated with shorter TWIST. In multifactorial analysis, higher age ( P = 0.001) FIGO stage ( P = 0.001) and total radiotherapy dose ( P < 0.001) were independent factors correlated with shorter TWIST.
Endometrial cancer patients treated with postoperative irradiation have a long time interval without relapse and severe late toxicity. However, when any late normal tissue injury is considered, the median time without relapse and late toxicity is significantly shorter. The impact of mild late radiotherapy complications on the quality of life should be further investigated. TWIST calculation should be attempted in future prospective studies evaluating the role of postoperative radiotherapy.
子宫内膜癌术后放疗可降低局部复发风险,但也会引发严重的急性和晚期反应。本研究旨在评估连续317例行术后放疗的子宫内膜癌患者的无瘤症状及毒性时间(TWIST)。
247例患者(78%)接受了低剂量率近距离放疗(BRT)和外照射放疗(EBRT),49例(15%)仅接受BRT,21例(7%)仅接受EBRT。中位随访时间为7.3年(范围4 - 21年)。采用Kaplan-Meier法进行基于无复发性疾病和放疗晚期效应的精算自由的TWIST分析。通过单因素和多因素检验评估患者及治疗相关因素对TWIST的影响。
5年总生存率为78%,5年无病生存率为75%。70例患者(22%)出现复发,其中11例(3.5%)仅在盆腔复发。任何级别的急性和晚期反应分别发生在268例(85%)和158例患者(51%)中。41%的患者出现任何级别的晚期肠道效应。35例患者(11%)出现严重晚期效应。无疾病和严重(3或4级)晚期效应(TWIST)的2年和5年精算概率分别为84%和71%(中位TWIST为16.2年)。当考虑所有级别的晚期效应时,2年和5年TWIST概率分别为50%和30%,中位TWIST仅为2.0年。当同时考虑急性和晚期反应时,中位TWIST为22个月。在单因素检验中,年龄较大(P = 0.013)、国际妇产科联盟(FIGO)分期(P < 0.001)、总放疗剂量(P < 0.001)、基于线性二次模型的归一化总剂量(P = 0.001)、EBRT分次剂量(P < 0.001)以及使用铯近距离放疗(P = 0.042)与较短的TWIST相关。在多因素分析中,年龄较大(P = 0.001)、FIGO分期(P = 0.001)和总放疗剂量(P < 0.001)是与较短TWIST相关的独立因素。
接受术后放疗的子宫内膜癌患者有较长的无复发和严重晚期毒性时间间隔。然而,当考虑任何晚期正常组织损伤时,无复发和晚期毒性的中位时间显著缩短。应进一步研究轻度放疗晚期并发症对生活质量的影响。在未来评估术后放疗作用的前瞻性研究中应尝试进行TWIST计算。